Exportació completada — 

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

BACKGROUND: The ‘Prediction Of Survival in Advanced Sorafenib‐treated HCC’ (PROSASH) model addressed the heterogeneous survival of patients with hepatocellular carcinoma (HCC) treated with sorafenib in clinical trials but requires validation in daily clinical practice. This study aimed to validate,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Int
Autors principals: Labeur, Tim A., Berhane, Sarah, Edeline, Julien, Blanc, Jean‐Frederic, Bettinger, Dominik, Meyer, Tim, Van Vugt, Jeroen L. A., Ten Cate, David W. G., De Man, Robert A., Eskens, Ferry A. L. M., Cucchetti, Alessandro, Bonnett, Laura J., Van Delden, Otto M., Klümpen, Heinz‐Josef, Takkenberg, R. Bart, Johnson, Philip J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Liver Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973249/
https://ncbi.nlm.nih.gov/pubmed/31579990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14270
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars